Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Francesca Marcon

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7439-8291; OpenAlex author ID A5075709863. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper

Papers 7

  1. Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC. Co-author DOI 10.1016/j.biopha.2024.116283↗
  2. Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade. Co-author DOI 10.1158/2326-6066.cir-22-0121↗
  3. Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma. Co-author DOI 10.7554/elife.86125↗
  4. Intention to treat outcomes among patients with pancreatic cancer treated using International Study Group on Pancreatic Surgery recommended pathways for resect… Co-author DOI 10.1111/ans.16643↗
  5. Recurrence patterns of pancreatic cancer after pancreatoduodenectomy: systematic review and a single-centre retrospective study. Co-author DOI 10.1016/j.hpb.2020.01.005↗
  6. NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype. Co-author DOI 10.1080/2162402x.2020.1845424↗
  7. Effect of intra-operative fluid volume on peri-operative outcomes after pancreaticoduodenectomy for pancreatic adenocarcinoma. First author DOI 10.1002/jso.22048↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Keith John Roberts · 6 shared papers, 2020–2024 · strength 0.78
  2. Sandra Margielewska‐Davies · 4 shared papers, 2020–2024 · strength 0.57
  3. Paul A. H. Moss · 4 shared papers, 2020–2024 · strength 0.57
  4. Hayden Pearce · 4 shared papers, 2020–2024 · strength 0.57
  5. Wayne D. Croft · 3 shared papers, 2023–2024 · strength 0.47
  6. Sarah F. Powell-Brett · 3 shared papers, 2023–2024 · strength 0.47
  7. Gary Middleton · 3 shared papers, 2020–2023 · strength 0.41
  8. Marit Kalisvaart · 2 shared papers, 2020–2021 · strength 0.21
  9. Robert Peter Sutcliffe · 2 shared papers, 2020–2021 · strength 0.21
  10. Nikolaos A. Chatzizacharias · 2 shared papers, 2020–2021 · strength 0.21
  11. Oladimeji Abudu · 1 shared paper, 2024 · strength 0.17
  12. Helen Michelle McGettrick · 1 shared paper, 2024 · strength 0.17
  13. Yuk Ting Ma · 1 shared paper, 2021 · strength 0.11
  14. Sivesh Kathir Kamarajah · 1 shared paper, 2021 · strength 0.11
  15. Pankaj Punia · 1 shared paper, 2021 · strength 0.11
  16. Rupaly Pandé · 1 shared paper, 2020 · strength 0.09
  17. Marcovalerio Melis · 1 shared paper, 2012 · strength 0.03
  18. Umut Sarpel · 1 shared paper, 2012 · strength 0.03
  19. Elliot Newman · 1 shared paper, 2012 · strength 0.03
  20. George Miller · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.